SCHEDULE 13G - MARAVAI LIFESCIENCES HOLDINGS, INC. (0001823239) (Subject)
Live Feed
Delayed 3mAnalyst · Buys · SEC · Financials
Signed out · 3-min delay · Sign up for real-time
- SEC Form SCHEDULE 13G filed by Maravai LifeSciences Holdings Inc.
- Large owner Aqua Capital, Ltd. bought $843,832 worth of shares (40,000 units at $21.10), increasing direct ownership by 0.55% to 7,340,000 units (SEC Form 4)
4 - ENERGIZER HOLDINGS, INC. (0001632790) (Issuer)
- SEC Form 144 filed by Dyne Therapeutics Inc.
144 - Dyne Therapeutics, Inc. (0001818794) (Subject)
- SEC Form 144 filed by Dyne Therapeutics Inc.
144 - Dyne Therapeutics, Inc. (0001818794) (Subject)
- ASUR PROPOSES TO ITS SHAREHOLDERS THE INTERNALIZATION OF TECHNICAL ASSISTANCE SERVICES, AN EXTRAORDINARY DIVIDEND, AND AN AMENDMENT TO THE COMPANY'S BYLAWS
MEXICO CITY, June 23, 2026 /PRNewswire/ -- Grupo Aeroportuario del Sureste, S.A.B. de C.V., (NYSE:ASR, BMV:ASUR) ASUR, a leading international airport group with operations in Mexico, the United States, and Colombia, announces that its Board of Directors has resolved to propose to our shareholders the integration of the technical assistance and technology transfer services business, which have been outsourced to our strategic partner, Inversiones y Técnicas Aeroportuarias, S.A.P.I. de C.V. "ITA," since the start of our operations and which we consider essential. Bringing these specialized technical assistance and technology transfer services in-house represents a significant step in our stra
- SEC Form SCHEDULE 13G filed by Arqit Quantum Inc.
SCHEDULE 13G - Arqit Quantum Inc. (0001859690) (Subject)
- SEC Form 144 filed by Kymera Therapeutics Inc.
144 - Kymera Therapeutics, Inc. (0001815442) (Subject)
- SEC Form 144 filed by Kymera Therapeutics Inc.
144 - Kymera Therapeutics, Inc. (0001815442) (Subject)
- Large owner Hrt Financial Lp bought $40,501 worth of shares (880,456 units at $0.05) and sold $528,894 worth of shares (136,665 units at $3.87), decreasing direct ownership by 68% to 123,944 units (SEC Form 4)
4 - WORK Medical Technology Group LTD (0001929783) (Issuer)
- Large owner Hrt Financial Lp sold $5,399 worth of shares (1,737 units at $3.11) and bought $19,516 worth of shares (6,872 units at $2.84), increasing direct ownership by 22% to 28,004 units (SEC Form 4)
4 - Vision Marine Technologies Inc. (0001813783) (Issuer)
- SEC Form 144 filed by SuRo Capital Corp.
144 - SURO CAPITAL CORP. (0001509470) (Subject)
- SEC Form 144 filed by Knight-Swift Transportation Holdings Inc.
144 - Knight-Swift Transportation Holdings Inc. (0001492691) (Subject)
- Amendment: SEC Form SCHEDULE 13D/A filed by Central Plains Bancshares Inc.
SCHEDULE 13D/A - Central Plains Bancshares, Inc. (0001979332) (Subject)
- Chief Executive Officer Eberwein Jeffrey E. bought $55,765 worth of Common Stock. (5,000 units at $11.15), increasing direct ownership by 0.45% to 1,115,714 units (SEC Form 4)
4 - Star Equity Holdings, Inc. (0001210708) (Issuer)
- SEC Form SCHEDULE 13G filed by Pasithea Therapeutics Corp.
SCHEDULE 13G - Pasithea Therapeutics Corp. (0001841330) (Subject)
- SEC Form 6-K filed by Rubico Inc.
6-K - Rubico Inc. (0001943421) (Filer)
- SEC Form 6-K filed by Rubico Inc.
6-K - Rubico Inc. (0001943421) (Filer)
- SEC Form 11-K filed by Janus Henderson Group plc
11-K - JANUS HENDERSON GROUP PLC (0001274173) (Filer)
- SEC Form 8-K filed by Enanta Pharmaceuticals Inc.
8-K - ENANTA PHARMACEUTICALS INC (0001177648) (Filer)